XML 40 R21.htm IDEA: XBRL DOCUMENT v3.25.1
EARNINGS PER SHARE
12 Months Ended
Dec. 31, 2024
EARNINGS PER SHARE  
EARNINGS PER SHARE

15. EARNINGS PER SHARE

The following represents the calculation of earnings (loss) per share (in thousands, except per share amounts):

Years Ended December 31,

    

2024

  

2023

Basic:

Net loss

$

(31,882)

$

(3,048)

Less: Preferred stock dividend

(32,219)

(12,047)

Less: Undistributed earnings allocable to preferred stockholders

Net (loss) income available to common stockholders

$

(64,101)

$

(15,095)

Weighted average basic number of common shares outstanding basic

16,457

16,441

Basic net (loss) income per share of common stock

$

(3.90)

$

(0.92)

Diluted:

Net (loss) income available to common stockholders basic

$

(64,101)

$

(15,095)

Reallocation of undistributed earnings

Net (loss) income available to common stockholders diluted

$

(64,101)

$

(15,095)

Weighted average basic number of common shares outstanding

16,457

16,441

Common stock equivalent shares representing shares issuable upon:

Exercise of stock options

Anti-dilutive

Anti-dilutive

Vesting of restricted stock units

Anti-dilutive

Anti-dilutive

Weighted average diluted number of common shares outstanding diluted

16,457

16,441

Diluted net income (loss) per share of common stock

$

(3.90)

$

(0.92)

For the year ended December 31, 2024, common stock equivalents, including stock options and certain restricted stock units, totaling 0.2 million weighted-average shares were anti-dilutive and not included in the computation of diluted earnings per share of common stock. For the year ended December 31, 2023, common stock equivalents, including stock options and certain restricted stock units, totaling 0.5 million weighted-average shares were anti-dilutive and not included in the computation of diluted earnings per share of common stock. Additionally, the Company also has less than 0.1 million restricted stock units that vest only upon achievement of certain business combination goals as further described in Note 13, “Stockholder’s Equity”.